A former Vertex scientist is setting his sights on an entire family of transporter proteins that can cause scores of rare inherited conditions. His startup, Rectify Pharmaceuticals, recently completed ...
“[...] it is crucial for the future application of ABC transporter inhibitors [...] to develop a stratification protocol [...] to identify those PDAC patients who ...
A new concept to target the proteasome: disrupting protein-protein interactions in the proteasome super-assembly as a way to stop the growth of cancer cells. This is an ASCO Meeting Abstract from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results